| scholarly article | Q13442814 |
| P2093 | author name string | Gregory G. Germino | |
| Luis Fernando Menezes | |||
| P2860 | cites work | WGCNA: an R package for weighted correlation network analysis | Q21284194 |
| A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis | Q24311615 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| Global, in vivo, and site-specific phosphorylation dynamics in signaling networks | Q27864128 | ||
| Repeatability of published microarray gene expression analyses | Q28307780 | ||
| Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study | Q28484968 | ||
| Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors | Q28508701 | ||
| PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2 | Q28585618 | ||
| Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease | Q28587166 | ||
| Network medicine: a network-based approach to human disease | Q29547462 | ||
| Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents | Q29615755 | ||
| Gene expression in early and progression phases of autosomal dominant polycystic kidney disease | Q30855836 | ||
| New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies | Q31122605 | ||
| Molecular advances in autosomal dominant polycystic kidney disease | Q33723862 | ||
| Diagnosis and screening of autosomal dominant polycystic kidney disease | Q33736708 | ||
| A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease | Q33784024 | ||
| Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients | Q33801052 | ||
| Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4α as a disease modifier. | Q34499444 | ||
| Parallel Analysis of mRNA and microRNA Microarray Profiles to Explore Functional Regulatory Patterns in Polycystic Kidney Disease: Using PKD/Mhm Rat Model | Q34551756 | ||
| Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks | Q34658323 | ||
| Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration | Q35843445 | ||
| Gene regulatory network analysis in sea urchin embryos. | Q35969921 | ||
| A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1 | Q36549183 | ||
| Urine proteome of autosomal dominant polycystic kidney disease patients | Q36715758 | ||
| Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor | Q36977390 | ||
| Characterization of PKD protein-positive exosome-like vesicles | Q37086680 | ||
| Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. | Q37092766 | ||
| Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley rat | Q37697510 | ||
| Polycystic kidney disease, cilia, and planar polarity. | Q37723498 | ||
| Expanding horizons: ciliary proteins reach beyond cilia | Q38135492 | ||
| Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling | Q38289224 | ||
| Global gene expression profiling in early-stage polycystic kidney disease in the Han:SPRD Cy rat identifies a role for RXR signaling | Q38504789 | ||
| The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation | Q40236123 | ||
| The biomarker enriched proteome of autosomal dominant polycystic kidney disease cyst fluid | Q40875866 | ||
| The polycystic kidney disease 1 gene product modulates Wnt signaling | Q40973635 | ||
| Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease | Q41891142 | ||
| Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1. | Q42015539 | ||
| Protein composition of liver cyst fluid from the BALB/c-cpk/+ mouse model of autosomal recessive polycystic kidney disease | Q42457669 | ||
| Scientific method: statistical errors | Q46088894 | ||
| Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany | Q46784859 | ||
| A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney | Q47074132 | ||
| The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. | Q48056738 | ||
| Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine | Q51594190 | ||
| Validation of gene regulatory networks: scientific and inferential | Q51621327 | ||
| Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease | Q51739894 | ||
| Gene profiling of polycystic kidneys. | Q53633652 | ||
| The robustness and evolvability of transcription factor binding sites. | Q54310563 | ||
| Transcriptome analysis of a rat PKD model: Importance of genes involved in extracellular matrix metabolism | Q60484105 | ||
| Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney disease | Q60728021 | ||
| cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway | Q73664706 | ||
| Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease | Q77998428 | ||
| Popper, laws, and the exclusion of biology from genuine science | Q81536474 | ||
| Identification of phosphoproteins in kidney tissues from patients with autosomal dominant polycystic kidney disease | Q82776016 | ||
| Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model | Q84417237 | ||
| Effects of specific genes activating RAGE on polycystic kidney disease | Q84532473 | ||
| Polycystic kidney disease: Polycystin-1 and polycystin-2--it's complicated | Q86559359 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systems biology | Q815297 |
| polycystic kidney disease | Q60195313 | ||
| P304 | page(s) | 39-52 | |
| P577 | publication date | 2015-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Wiley interdisciplinary reviews. Systems biology and medicine | Q26842017 |
| P1476 | title | Systems biology of polycystic kidney disease: a critical review | |
| P478 | volume | 7 |
| Q47653590 | A Report of the 24th Annual Congress on Women's Health-Workshop on Transforming Women's Health: From Research to Practice |
| Q38985868 | Meta-analysis of polycystic kidney disease expression profiles defines strong involvement of injury repair processes. |
| Q64252507 | Metabolomics Approaches for the Diagnosis and Understanding of Kidney Diseases |
| Q41247634 | Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis. |
| Q52603808 | Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease |
| Q100490958 | The tissue proteome in the multi-omic landscape of kidney disease |
| Q37426288 | Transcriptome analysis reveals manifold mechanisms of cyst development in ADPKD. |
Search more.